SLU-PP-332, chemically known as (E)-4-Hydroxy-N-(naphthalen-2-ylmethylene)benzohydrazide, is a non-hormonal small molecule used in controlled research environments as a model compound in studies involving ERR-associated pathways, receptor interaction systems, and transcription-related signalling models
The company, which has ties to Marty Makary, President Donald Trumps pick to lead the FDA, also said its working with manufacturers to secure deeper discounts on the medications in late 2025 and into 2026
Dermatologists estimate that up to 90% of visible skin aging is caused by UV radiation and Florida's near-constant sunshine means cumulative photodamage accumulates faster here than virtually anywhere else in the country
Clinical research shows improved blood sugar, heart health, sleep & muscle preservation
The dual-receptor activation affects appetite, blood sugar control, and metabolic rate through complementary biological pathways that single-agent therapies cannot replicate
